Rate this post

MedVi vs UrWay Health: Compare GLP-1 Programs & Pricing

Side-by-side MedVi and UrWay Health: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

MedVi and UrWay Health are two established telehealth providers offering GLP-1–based weight management programs. This article compares MedVi vs UrWay Health to help you identify which best fits your goals and preferences.

Visit MedVi
Explore UrWay Health

MedVi vs UrWay Health: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
MedVi	$179.00	$279.00	$120 off first month (Code: )	— No
UrWay Health			(Code: )	— No

MedVi vs UrWay Health: Medical Process & Accessibility

MedVi focuses on a streamlined telehealth intake that can be completed in under 10 minutes, followed by clinician approval and rapid prescription fulfillment. UrWay Health offers a more structured onboarding experience with a detailed health questionnaire, a video consult, and scheduled follow‑up visits for dose titration. Both platforms are 100% virtual, comply with FDA telemedicine regulations, and partner with licensed U.S. pharmacies for compounded GLP‑1 prescriptions.

Start with MedVi

MedVi vs UrWay Health: Pricing Comparison

MedVi starts semaglutide at $179.00 and tirzepatide at $279.00. UrWay Health does not currently list publicly disclosed starting prices, which means MedVi’s transparent pricing is often the lower (and only) known cost. Both providers advertise a first‑month discount – MedVi offers “$120 off first month” while UrWay Health has no published promo at this time.

Neither provider requires a membership fee, so the listed medication price reflects the out‑of‑pocket cost before any insurance contributions (if applicable). Be sure to verify whether your health plan covers compounded GLP‑1 products, as coverage can vary widely.

Compare UrWay Health Pricing

MedVi vs UrWay Health: Clinical Oversight & Support

Both companies assign board‑certified physicians or nurse practitioners to review your medical history, confirm eligibility for GLP‑1 therapy, and monitor safety labs (e.g., fasting glucose, kidney function). MedVi’s model emphasizes rapid prescription turnaround—often within 24‑48 hours of approval—making it attractive for users who want to start quickly.

UrWay Health, on the other hand, builds a longer‑term relationship through monthly video check‑ins, personalized dose‑adjustment plans, and a dedicated patient‑care portal where you can message your clinician directly. This ongoing support can be beneficial for individuals who anticipate side‑effects or who need more frequent titration.

Book a Consultation with MedVi

MedVi vs UrWay Health: Medication Quality & Safety

Both platforms dispense compounded semaglutide or tirzepatide from FDA‑registered compounding pharmacies that follow Good Manufacturing Practices (GMP). While these formulations are not the exact brand‑name products (Wegovy® for semaglutide, Mounjaro® for tirzepatide), they contain the same active ingredient and are prescribed under the supervision of a licensed clinician, meeting FDA telehealth guidelines.

Patients are required to provide recent lab results and complete a baseline health questionnaire to ensure no contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN‑2). Ongoing safety monitoring includes periodic weight checks, blood glucose reviews, and assessment for gastrointestinal side‑effects.

Explore UrWay Health Reviews

MedVi vs UrWay Health: Shipping & Delivery

Both companies ship directly to your door via USPS or UPS, typically within 5‑7 business days after prescription approval. MedVi offers free standard shipping on orders over $150, while UrWay Health provides complimentary shipping on all orders, regardless of amount. Expedited shipping options are available for an additional fee.

All packages are discreetly labeled, and you receive a tracking number via email and the patient portal. If you have a tight start‑date, MedVi’s faster approval workflow may give you a slight edge.

Join MedVi
Get Started with UrWay Health

MedVi vs UrWay Health: Customer Experience & Satisfaction

Customer reviews on independent forums frequently cite MedVi’s affordability and quick onboarding as primary strengths. Users appreciate the clear pricing table and the $120 first‑month discount, which reduces the initial barrier to trying GLP‑1 therapy.

UrWay Health reviewers often highlight the personalized care team, thorough educational resources, and proactive dose‑titration guidance. Some note that the longer intake process feels more “clinical” and can be reassuring for first‑time users wary of side‑effects.

Both platforms maintain a 4‑star average rating across major review sites, indicating overall satisfaction with medication effectiveness, shipping speed, and clinician communication.

MedVi vs UrWay Health: Frequently Asked Questions

Are GLP‑1 compounds FDA‑approved?

Compounded semaglutide and tirzepatide are not the brand‑name products that have FDA approval, but the active ingredients are identical. When prescribed by a licensed clinician and compounded in a certified pharmacy, they are considered legal and safe under federal telehealth regulations.

Do I need insurance?

Insurance coverage for compounded GLP‑1 medications is limited. Both MedVi and UrWay Health allow you to submit a superbill for potential reimbursement, but many patients pay out‑of‑pocket.

What labs are required?

Both providers request recent fasting glucose, HbA1c, kidney function (eGFR), and a basic metabolic panel. These labs help determine safety and appropriate dosing.

Can I switch providers after starting?

Yes. Because each provider uses a separate pharmacy, you can discontinue one program and begin another after a suitable wash‑out period, typically 2‑4 weeks, under clinician guidance.

Start Your GLP‑1 Journey with MedVi

MedVi vs UrWay Health: Final Verdict

If you prioritize a low‑cost entry point, rapid prescription fulfillment, and a straightforward discount, MedVi is the clear choice. Its transparent pricing and $120 first‑month savings make it attractive for budget‑conscious patients.

If you value ongoing clinical monitoring, a structured titration schedule, and a more hands‑on support team, UrWay Health may better suit your needs, even though price details are less public.

Both platforms comply with telehealth and FDA regulations, partner with accredited U.S. pharmacies, and provide legitimate access to semaglutide and tirzepatide for weight‑management or glycemic control. Your decision should hinge on which service model aligns with your personal timeline, budget, and desire for clinical interaction.

Join MedVi Today
Enroll with UrWay Health

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice